Category: Workers Comp

529 posts found

Medmonitor

FDA Orders Opioid Manufacturers to Update Prescribing Information for Long-Term Use

All opioid manufacturers must update their drug labeling to align with a list of notes provided by the FDA.

This Month's Must Read

Burden of Proof: Unpacking Presumptions in Workers’ Comp

Exploring the expansion of presumptions in PTSD, cancers, and more.

Medmonitor

FDA Requires New Kidney Injury Warning for All GLP-1 Drugs

Dehydration from these drugs can lead to kidney damage, requiring hemodialysis treatment.

Clinical Insights

New Study Links Frequent Gabapentin Use to Higher Risk for Cognitive Impairment

Patients who had six or more gabapentin prescriptions were 85% more likely to experience mild cognitive impairment, and 29% were at higher risk for dementia.

Legislation & Policy

FDA Takes Steps to Restrict Certain Kratom Products

The FDA recommended concentrated 7-OH kratom products to be rescheduled under the Controlled Substances Act.

Healthe Developments

Driving More Personalized Care Through Strategic Formulary Design

Healthesystems Manager of Clinical Services, Britten Featherston, shares with WorkCompWire how formularies are powerful tools in effectively managing the unique needs of injured worker populations.

Healthe Developments

The Emerging Role of AI in Workers’ Comp – and the Regulations Surrounding It

An expert Q&A with Sandy Shtab, VP of Industry and State Affairs, on AI in workers’ comp and the regulations surrounding it.

This Month's Must Read

Pain Points: Chronic Pain and the Injured Worker

Consequences for injured workers and in the workplace, from absenteeism to higher healthcare costs, and more.

Legislation & Policy

Nevada Enacts Workers’ Comp Formulary

The state will adopt the ODG Drug Formulary by July 1, 2027, with coverage of non-formulary drugs allowed through January 1, 2028.

Clinical Insights

CWCI Publishes Report on Long-COVID

Long COVID cases made up 4.7% of COVID claims, totaling 6,000 claims, yet their medical payments totaled $105 million.

Industry Insights

WCRI Publishes New Report on Medical Fee Schedule Design

The study compares workers’ comp fee schedules for professional services to Medicare rates within 44 states, accounting for 41% of medical costs.

Healthe Developments

Healthesystems at WCI 2025

Visit Healthe at Booth #921 to learn about our solutions and how we reduce burdens for claims professionals.

Medmonitor

Brekiya Approved for the Acute Treatment of Migraine

Dihydroergotamine mesylate injections are approved for the acute treatment of migraine with or without aura, and for the acute treatment of cluster headaches.